Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infections with flaviviridae.

J Neyts1, P Leyssen, E De Clercq

  • 1Rega Institute for Medical Research, KULeuven.

Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|February 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992
Same author

Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.

Molecular pharmacology·1992
Same author

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Antimicrobial agents and chemotherapy·1992
Same author

Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1992
Same author

3'-C-branched 2'-deoxy-5-methyluridines: synthesis, enzyme inhibition, and antiviral properties.

Journal of medicinal chemistry·1992
Same author

Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives.

Journal of medicinal chemistry·1992

Hepatitis C virus (HCV) affects millions globally, with limited treatment options. Researchers developed a new mouse model to study flavivirus infections, aiding in the search for effective antiviral therapies.

Area of Science:

  • Virology
  • Infectious Diseases
  • Immunology

Background:

  • The Flaviviridae family includes Hepatitis C virus (HCV), flaviviruses, and pestiviruses, causing significant human and livestock diseases.
  • HCV chronically infects over 140 million people worldwide, with current treatments limited to interferon and ribavirin.
  • Emerging flavivirus infections like Dengue and West Nile virus pose global health threats, necessitating new therapeutic strategies.

Purpose of the Study:

  • To establish a small animal model for studying flavivirus infections, particularly for Hepatitis C virus (HCV) research.
  • To overcome limitations in current HCV research, including the lack of efficient cell culture systems and small animal models.
  • To facilitate the development of novel antiviral therapies targeting Flaviviridae family viruses.

Main Methods:

Related Experiment Videos

  • Established a small animal model using SCID mice.
  • Inoculated SCID mice peripherally with the murine flavivirus Modoc.
  • Utilized this model to study flavivirus infection dynamics and potential therapeutic targets.

Main Results:

  • Successfully developed a peripheral inoculation model for flavivirus infection in SCID mice.
  • This model allows for the study of flavivirus pathogenesis and the evaluation of antiviral interventions.
  • The model provides a platform for investigating potential targets such as viral proteases, RNA polymerase, and helicase.

Conclusions:

  • The developed SCID mouse model offers a viable system for flavivirus research, addressing limitations of previous models.
  • This advancement is crucial for understanding flavivirus replication and for the discovery of new antiviral drugs.
  • The model supports the ongoing search for effective treatments against a range of flavivirus infections.